JP2012510803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510803A5 JP2012510803A5 JP2011539034A JP2011539034A JP2012510803A5 JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5 JP 2011539034 A JP2011539034 A JP 2011539034A JP 2011539034 A JP2011539034 A JP 2011539034A JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- isolated peptide
- nucleic acid
- protease
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 108091005804 Peptidases Proteins 0.000 claims 7
- 239000004365 Protease Substances 0.000 claims 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 229940122199 Insulin secretagogue Drugs 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical group C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 claims 1
- 241000235648 Pichia Species 0.000 claims 1
- 102000007562 Serum Albumin Human genes 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12013508P | 2008-12-05 | 2008-12-05 | |
| US61/120,135 | 2008-12-05 | ||
| PCT/EP2009/066395 WO2010063818A2 (en) | 2008-12-05 | 2009-12-04 | Methods for selecting protease resistant polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147120A Division JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012510803A JP2012510803A (ja) | 2012-05-17 |
| JP2012510803A5 true JP2012510803A5 (enExample) | 2013-01-31 |
| JP5840498B2 JP5840498B2 (ja) | 2016-01-06 |
Family
ID=42169477
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539034A Active JP5840498B2 (ja) | 2008-12-05 | 2009-12-04 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
| JP2015147120A Pending JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147120A Pending JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8685895B2 (enExample) |
| EP (1) | EP2364326B1 (enExample) |
| JP (2) | JP5840498B2 (enExample) |
| KR (1) | KR101740066B1 (enExample) |
| CN (1) | CN102307897B (enExample) |
| AU (1) | AU2009324037B2 (enExample) |
| BR (1) | BRPI0922772B1 (enExample) |
| CA (1) | CA2745448C (enExample) |
| EA (1) | EA026508B1 (enExample) |
| ES (1) | ES2688621T3 (enExample) |
| IL (1) | IL212923A0 (enExample) |
| MX (1) | MX2011005874A (enExample) |
| SG (1) | SG194383A1 (enExample) |
| WO (1) | WO2010063818A2 (enExample) |
| ZA (1) | ZA201103575B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685895B2 (en) * | 2008-12-05 | 2014-04-01 | Carolyn Enever | Methods for selecting protease resistant polypeptides |
| US9012609B2 (en) | 2010-08-13 | 2015-04-21 | Glaxosmithkline Intellectual Property Development Limited | Anti-serum albumin binding variants |
| KR20130055663A (ko) * | 2010-08-20 | 2013-05-28 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 개선된 항-혈청 알부민 결합 변이체 |
| EP2866029B1 (en) * | 2012-06-22 | 2017-05-03 | Olympus Corporation | Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature |
| AU2014290229A1 (en) * | 2013-07-15 | 2016-02-18 | North Carolina State University | Protease-resistant peptide ligands |
| JP6422977B2 (ja) * | 2013-08-30 | 2018-11-14 | エイプリルバイオ カンパニー リミテッド | 抗血清アルブミンfabエフェクター部分融合コンストラクト、およびその製造方法 |
| WO2016191659A1 (en) * | 2015-05-28 | 2016-12-01 | Bio-Rad Laboratories, Inc. | Affinity ligands and methods relating thereto |
| TWI726889B (zh) * | 2015-06-10 | 2021-05-11 | 英商梅迪繆思有限公司 | 蛋白酶抗性之脂化肽 |
| JP6766253B2 (ja) * | 2017-03-28 | 2020-10-07 | 森永乳業株式会社 | 新規ビフィドバクテリウム属細菌 |
| KR20210143766A (ko) * | 2019-02-26 | 2021-11-29 | 트위스트 바이오사이언스 코포레이션 | Glp1 수용체에 대한 변이체 핵산 라이브러리 |
| US11584781B2 (en) * | 2019-12-30 | 2023-02-21 | Eligo Bioscience | Chimeric receptor binding proteins resistant to proteolytic degradation |
| KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| US12391762B2 (en) | 2020-08-26 | 2025-08-19 | Twist Bioscience Corporation | Methods and compositions relating to GLP1R variants |
| US12122817B2 (en) * | 2020-09-22 | 2024-10-22 | Serpentide Inc. | Long-lasting GLP1 analogue drug for type-2 diabetes |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
| WO1989007142A1 (en) | 1988-02-05 | 1989-08-10 | Morrison Sherie L | Domain-modified constant region antibodies |
| EP1997891A1 (en) | 1988-09-02 | 2008-12-03 | Dyax Corporation | Generation and selection of recombinant varied binding proteins |
| ATE92107T1 (de) | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| WO1994029351A2 (en) | 1993-06-16 | 1994-12-22 | Celltech Limited | Antibodies |
| US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
| CA2229043C (en) | 1995-08-18 | 2016-06-07 | Morphosys Gesellschaft Fur Proteinoptimierung Mbh | Protein/(poly)peptide libraries |
| DK1801214T3 (da) | 1997-07-07 | 2011-01-24 | Medical Res Council | In vitro sorteringsfremgangsmåde |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| ATE380865T1 (de) | 1998-05-13 | 2007-12-15 | Domantis Ltd | Phagen-display-selektionssystem für korrekt gefaltete proteine |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| JP2003523742A (ja) | 2000-02-03 | 2003-08-12 | ドマンティス リミテッド | コンビナトリアルタンパク質ドメイン |
| DK1355942T3 (da) | 2000-12-07 | 2008-11-17 | Lilly Co Eli | GLP-1-fusionsproteiner |
| WO2002095076A2 (en) * | 2001-05-23 | 2002-11-28 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Modified polypeptides having protease-resistance and/or protease-sensitivity |
| DK1412384T3 (da) | 2001-06-28 | 2008-04-28 | Novo Nordisk As | Stabil formulering af modificeret GLP-1 |
| WO2003076567A2 (en) | 2002-03-05 | 2003-09-18 | Eli Lilly And Company | Heterologous g-csf fusion proteins |
| US20060002935A1 (en) | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| EP3299393A1 (en) | 2002-11-08 | 2018-03-28 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| TW200526254A (en) | 2003-09-19 | 2005-08-16 | Novo Nordisk As | Novel GLP-1 derivatives |
| PT1737962E (pt) | 2004-03-24 | 2010-12-03 | Domantis Ltd | Sequência líder universal gas1 |
| CA2589800A1 (en) * | 2004-12-02 | 2006-06-08 | Domantis Limited | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| MX2009003400A (es) * | 2006-10-03 | 2009-04-28 | Cadila Healthcare Ltd | Compuestos antidiabeticos. |
| GB0724331D0 (en) * | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
| EP2259802A1 (en) * | 2008-03-31 | 2010-12-15 | Glaxo Group Limited | Drug fusions and conjugates |
| US8685895B2 (en) * | 2008-12-05 | 2014-04-01 | Carolyn Enever | Methods for selecting protease resistant polypeptides |
| EA027866B1 (ru) * | 2009-02-19 | 2017-09-29 | Глэксо Груп Лимитед | Улучшенные связывающие сывороточный альбумин варианты |
-
2009
- 2009-12-04 US US13/131,640 patent/US8685895B2/en active Active
- 2009-12-04 JP JP2011539034A patent/JP5840498B2/ja active Active
- 2009-12-04 MX MX2011005874A patent/MX2011005874A/es not_active Application Discontinuation
- 2009-12-04 WO PCT/EP2009/066395 patent/WO2010063818A2/en not_active Ceased
- 2009-12-04 SG SG2013073069A patent/SG194383A1/en unknown
- 2009-12-04 AU AU2009324037A patent/AU2009324037B2/en not_active Ceased
- 2009-12-04 CN CN200980156194.1A patent/CN102307897B/zh active Active
- 2009-12-04 CA CA2745448A patent/CA2745448C/en active Active
- 2009-12-04 EA EA201170762A patent/EA026508B1/ru not_active IP Right Cessation
- 2009-12-04 EP EP09764259.9A patent/EP2364326B1/en active Active
- 2009-12-04 BR BRPI0922772-5A patent/BRPI0922772B1/pt active IP Right Grant
- 2009-12-04 ES ES09764259.9T patent/ES2688621T3/es active Active
- 2009-12-04 KR KR1020117015383A patent/KR101740066B1/ko not_active Expired - Fee Related
-
2011
- 2011-05-16 IL IL212923A patent/IL212923A0/en unknown
- 2011-05-16 ZA ZA2011/03575A patent/ZA201103575B/en unknown
-
2014
- 2014-02-10 US US14/176,231 patent/US10466252B2/en active Active
-
2015
- 2015-07-24 JP JP2015147120A patent/JP2015231380A/ja active Pending
-
2017
- 2017-08-17 US US15/679,191 patent/US10302655B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012510803A5 (enExample) | ||
| JP2023179436A5 (enExample) | ||
| US20130040877A1 (en) | Long-acting y2 receptor agonists | |
| NZ596778A (en) | Glucose-regulating polypeptides and methods of making and using same | |
| NZ597685A (en) | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli | |
| JP2010529860A5 (enExample) | ||
| JP2014510518A5 (enExample) | ||
| JP2013545724A5 (enExample) | ||
| JP2007513634A5 (enExample) | ||
| JP2016512213A5 (enExample) | ||
| JP2016512213A (ja) | 肥満の治療のためのペグ化グルカゴン及びglp−1コアゴニスト | |
| US20210221866A1 (en) | Protease-resistant lipidated glp-1 analogs | |
| JP2015504052A5 (enExample) | ||
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
| WO2023148366A1 (en) | Glp-1 and glucagon dual agonist peptides with improved biological stability | |
| CY1111630T1 (el) | Παραγωγα κυτοκινων | |
| KR20190017017A (ko) | 프로테아제-내성 모노-지질화된 펩타이드 | |
| WO2006111946A3 (en) | Toll-like receptor 14 (tlr14 ) and use thereof | |
| JP2020511425A5 (enExample) | ||
| JP2008517998A5 (enExample) | ||
| WO2007064844A3 (en) | Anti-viral griffithsin compounds, compositions, and methods of use | |
| DK1913020T3 (da) | Immunogene konstrukter | |
| WO2008029138A3 (en) | Peptides and methods | |
| DK1960515T3 (da) | Inflammationshæmmende peptider |